entertainment -WSS

entertainment

author：focus 2025-10-03 00:38:04 - browse：79

Drugmakers already bet big on mRNA for cancer. Now President Biden is going in, too? Anna Moneymaker/Getty Images

WASHINGTON — President Biden’s fledgling health agency, designed to accelerate under-funded research, just set its sights on one of the hottest areas of medicine — and one where the drug industry has a multibillion-dollar head start.

The White House announced Wednesday that the Advanced Research Projects Agency for Health would bankroll a $24 million project by Emory University to build messenger RNA platforms to target “cancer and other diseases,” investing in the technology behind the U.S.’s most commonly used vaccines for Covid-19.

The administration touted the news of CUREIT as the latest in Biden’s longtime mission to rein in cancer deaths, the Cancer Moonshot. But by using mRNA to treat cancer, ARPA-H is wading into a field that has advanced in fits and starts — and whose industry leaders have already spent multiples of the program’s entire budget into their own research. Moderna and BioNTech, massively profitable companies that have sold more than $80 billion worth of Covid-19 vaccines combined, have singled out oncology as the next big application for mRNA and invested accordingly.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Boston hospital trains restaurant workers on naloxone for overdoses

focus

WSS

Medicare drug price negotiation hasn't dried up venture capital

What STAT readers think about the FDA and patient advocacy

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Hottest summer in 2,000 years puts focus on extreme heat, health

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Novo Nordisk testing Wegovy against alcohol

Wikipedia

entertainment

hotspot

At least 13 dead in Texas as scorching temps continue

Carvykti CAR

23andMe had bad news about my health. I wish a person had delivered it

Free medical tuition alone isn't enough to close gaps in primary care

Medicare proposal to cover medical devices draws a mixed reaction

Can sheer will power keep patients alive in their dying hours?

Medical leaders decry Supreme Court decision on affirmative action

The White House hikes tariffs on plastic syringes made in China

How one medical school became remarkably diverse

Why health care costs have stayed mostly flat since 2010

hotspot

Keeping primary care docs in field isn't impossible, says AAFP CEO

What STAT readers think about the FDA and patient advocacy

The White House hikes tariffs on plastic syringes made in China

Hottest summer in 2,000 years puts focus on extreme heat, health

Galapagos to make CAR

HHS suspends federal funding for EcoHealth Alliance

entertainment

hotspot

focus

Wikipedia